about
Skin resurfacing procedures: new and emerging optionsTopical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skinGenetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivoHyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitroUVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor SignalingThe IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer.STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitisNoninvasive mesoscopic imaging of actinic skin damage using spatial frequency domain imaging.Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production.Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasisToxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis.Identification of staphylococcal protein A in infected atopic dermatitis lesions.Identification of platelet-activating factor acetylhydrolase II in human skin.Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skinChemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.Hydrofluoric acid exposure: a case report and review on the clinical presentation and management.Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.Important implications and new uses of ablative lasers in dermatology: fractional carbon dioxide laser prevention of skin cancer.Acquired STAT4 deficiency as a consequence of cancer chemotherapy.Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells.Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesisPlatelet-activating factor does not mediate UVB-induced local immune suppressionOxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53.Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis.p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics.Radiation therapy generates platelet-activating factor agonistsImatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.PARP14 limits severity of allergic skin disease.Examining the differences in current regulatory processes for sunscreens and proposed safety assessment paradigm.Impact of Age and Insulin-Like Growth Factor-1 on DNA Damage Responses in UV-Irradiated Human Skin.UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects.cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors.Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor.
P50
Q24563693-B323207D-C8B8-40D8-A920-4949F86E7771Q28544768-8AA06D15-79BA-4E5C-B1B7-6C1AAE68485CQ28585229-F6532507-02F1-4777-8D14-B3C19580A76EQ28594862-E9DBFB63-BE83-41BB-A906-603E9BA007E9Q33664877-8EE4A4AB-9C5D-455B-ABE7-AF16FC737A10Q33721751-94A30CE7-DCF7-4516-A0D9-4E7389BD3DF8Q33773485-645EAE71-726E-48CA-B146-CA790F3D0B9CQ33824495-3813B9C6-5B31-4F4F-B251-AE505720879EQ33872427-D282488C-2007-49B2-B40D-7C782A396EF9Q33877619-2C0C0D56-F92C-4DBF-AB2D-B33251F5DABEQ33901930-C7556DC5-CBDB-4909-95B2-BEBA1BAA04D4Q33914386-E7F2573F-D34D-4DE4-9BA9-83EC6847C3F5Q34110713-B892D00A-58A7-4BE7-9683-5BB495B6CBA7Q34156771-4F1E095D-3C5B-4647-8888-1A249199F653Q34179222-6E009A8C-136A-48FC-9E0D-2F07CD2A0AD8Q34613089-29D66898-7F9D-4D0F-8E65-BAF139C316C5Q34643090-4FC741D1-FB30-441D-847E-E352E3E183D8Q34716311-43286217-7A60-47B5-A4C3-757A7A3453C5Q34720289-B4178BB3-E2AD-4F51-865A-052F996C3805Q35438088-D987E4BA-97AF-452B-BA5E-9E04908F3A9DQ35572295-0A40228E-B891-494D-9C4C-01A46862B771Q35604056-18179624-2E48-493B-A6C8-84BE82EAC42FQ35645419-1EB51808-DB53-4249-92DD-74B01B0B11BCQ35795383-9573D679-963F-459E-8D12-9C8BE687F7AFQ35798982-B4FDCE54-FA60-4AC4-B890-D641D56A6AB8Q35932617-14D2EE6F-83F3-4DB5-9469-B0804A6B126CQ36118884-7CC5CB6A-1321-4A3B-A6DA-BAF0FE7F02AFQ36178572-4D8820AC-CDBF-42BA-B3CA-218D181AB654Q36536607-22A8D844-A89B-4676-9C6D-072D3525322EQ36814937-55F96D55-A44B-4077-94ED-210A86A3CB69Q37142159-EA890168-8552-434B-B760-B3F21BB7FF88Q37190440-DC8ABEA9-B4B8-4480-A95C-AF5C72074AC8Q37737382-7011573C-59E3-4142-891A-3A5EEFC1C9E0Q38408903-F93F195A-C981-409C-9E51-E4219CF268BEQ38707649-40BF6EDC-D305-4A64-9866-A0ED7CC60429Q38889998-72CE8C3B-6577-4E0D-B4AD-167A409FE667Q38937094-FEDF9C84-2218-45E0-BE18-81C8770632F7Q39047723-D3BBC438-A683-4DFA-B6BF-3E86BD813945Q39846321-FEF56E6D-4164-4573-BE4E-76FC1968344EQ40069379-C75ED0D0-1889-48FE-9BE6-AA8CDB390197
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeffrey B Travers
@ast
Jeffrey B Travers
@en
Jeffrey B Travers
@es
Jeffrey B Travers
@nl
type
label
Jeffrey B Travers
@ast
Jeffrey B Travers
@en
Jeffrey B Travers
@es
Jeffrey B Travers
@nl
prefLabel
Jeffrey B Travers
@ast
Jeffrey B Travers
@en
Jeffrey B Travers
@es
Jeffrey B Travers
@nl
P108
P106
P108
P1153
35512895600
P31
P496
0000-0001-7232-1039